Individual legislator voting records for this vote are not currently available. Includes all politicians who were in office at any point during the 2013-2014 Legislature.

SB 598 - An Act to Add Section 4073.5 to the Business and Professions Code, Relating to Pharmacy.

Biosimilars. 2013-2014 Legislature. View bill details
Author(s):
Summary:
The Pharmacy Law governs the practice of pharmacy in this state, including the permissible duties of licensed pharmacists. Among other permitted acts, a pharmacist filling a prescription order for a drug product prescribed by its trade or brand name may select another drug product with the same active chemical ingredients of the same strength, quantity, and dosage form, and of the same generic… More
The Pharmacy Law governs the practice of pharmacy in this state, including the permissible duties of licensed pharmacists. Among other permitted acts, a pharmacist filling a prescription order for a drug product prescribed by its trade or brand name may select another drug product with the same active chemical ingredients of the same strength, quantity, and dosage form, and of the same generic drug name as determined, as specified, of those drug products having the same active chemical ingredients. A person who knowingly violates the Pharmacy Law is guilty of a misdemeanor, as specified.

This bill would authorize a pharmacist, in his or her discretion, except as specified, to select a biosimilar, as defined, when filling a prescription order for a prescribed biological product only if the product has been approved by the federal Food and Drug Administration, as specified, and the prescriber does not personally indicate “Do not substitute,” as specified. The bill would also require, for prescriptions filled prior to January 1, 2017, the pharmacy to, within 5 business days of the selection of a biological product or an interchangeable biosimilar, notify the prescriber or enter in a patient record whether the prescription dispensed was a biological product or an interchangeable biosimilar, except as specified. The bill would prohibit a pharmacist from selecting a biosimilar that meets the requirements of these provisions unless the cost to the patient of the biosimilar selected is the same or less than the cost of the prescribed biological product. The bill would also require that the substitution of a biosimilar be communicated to the patient. Because a knowing violation of these requirements would be a misdemeanor, the bill would create new crimes, thereby imposing a state-mandated local program.

The bill would also require the California State Board of Pharmacy to maintain on its public Internet Web site a link to the current list, if available, of biosimilar products determined by the federal Food and Drug Administration to be interchangeable, as specified.

The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.

This bill would provide that no reimbursement is required by this act for a specified reason. Hide
 
Status:
This bill was passed by both houses and vetoed by the Governor. It did not become law
Senate Vote: On Passage

PASSED on September 4, 2013.

voted YES: 30 voted NO: 2
7 voted present/not voting

An Act to Add Section 4073.5 to the Business and Professions Code, Relating to Pharmacy.

SB 598 — 2013-2014 Legislature

Summary
The Pharmacy Law governs the practice of pharmacy in this state, including the permissible duties of licensed pharmacists. Among other permitted acts, a pharmacist filling a prescription order for a drug product prescribed by its trade or brand name may select another drug product with the same active chemical ingredients of the same strength, quantity, and dosage form, and of the same generic drug name as determined, as specified, of those drug products having the same active chemical ingredients. A person who knowingly violates the Pharmacy Law is guilty of a misdemeanor, as specified.

This bill would authorize a pharmacist, in his or her discretion, except as specified, to select a biosimilar, as defined, when filling a prescription order for a prescribed biological product only if the product has been approved by the federal Food and Drug Administration, as specified, and the prescriber does not personally indicate “Do not substitute,” as specified. The bill would also require, for prescriptions filled prior to January 1, 2017, the pharmacy to, within 5 business days of the selection of a biological product or an interchangeable biosimilar, notify the prescriber… More
The Pharmacy Law governs the practice of pharmacy in this state, including the permissible duties of licensed pharmacists. Among other permitted acts, a pharmacist filling a prescription order for a drug product prescribed by its trade or brand name may select another drug product with the same active chemical ingredients of the same strength, quantity, and dosage form, and of the same generic drug name as determined, as specified, of those drug products having the same active chemical ingredients. A person who knowingly violates the Pharmacy Law is guilty of a misdemeanor, as specified.

This bill would authorize a pharmacist, in his or her discretion, except as specified, to select a biosimilar, as defined, when filling a prescription order for a prescribed biological product only if the product has been approved by the federal Food and Drug Administration, as specified, and the prescriber does not personally indicate “Do not substitute,” as specified. The bill would also require, for prescriptions filled prior to January 1, 2017, the pharmacy to, within 5 business days of the selection of a biological product or an interchangeable biosimilar, notify the prescriber or enter in a patient record whether the prescription dispensed was a biological product or an interchangeable biosimilar, except as specified. The bill would prohibit a pharmacist from selecting a biosimilar that meets the requirements of these provisions unless the cost to the patient of the biosimilar selected is the same or less than the cost of the prescribed biological product. The bill would also require that the substitution of a biosimilar be communicated to the patient. Because a knowing violation of these requirements would be a misdemeanor, the bill would create new crimes, thereby imposing a state-mandated local program.

The bill would also require the California State Board of Pharmacy to maintain on its public Internet Web site a link to the current list, if available, of biosimilar products determined by the federal Food and Drug Administration to be interchangeable, as specified.

The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.

This bill would provide that no reimbursement is required by this act for a specified reason. Hide
Learn More
At LegInfo.ca.gov
Title
An Act to Add Section 4073.5 to the Business and Professions Code, Relating to Pharmacy.
Author(s)
Jerry Hill
Co-Authors
Subjects
  • Biosimilars
Major Actions
Introduced2/22/2013
Referred to Committee
Passed Senate Committee on Business, Professions and Economic Development4/08/2013
Passed Senate Committee on Health5/01/2013
Passed Senate5/24/2013
Passed Assembly Committee on Business, Professions and Consumer Protection6/25/2013
Passed Assembly Committee on Health7/02/2013
Passed Assembly Committee on Appropriations8/21/2013
Passed Assembly8/26/2013
Passed Senate9/04/2013
Presented to the governor (enrolled)9/23/2013
Vetoed by Governor10/12/2013
Vetoed by Governor10/12/2013
Bill History
Chamber/CommitteeMotionDateResult
select this voteSenate Committee on Business, Professions and Economic DevelopmentDo pass as amended, and re-refer to the Committee on Health.4/08/2013This motion PASSED the Senate Committee on Business, Professions and Economic Development
10 voted YES 0 voted NO 0 voted present/not voting
select this voteSenate Committee on HealthDo pass, but re-refer to the Committee on Appropriations.5/01/2013This motion PASSED the Senate Committee on Health
6 voted YES 1 voted NO 2 voted present/not voting
select this voteSenateSenate 3rd Reading SB598 Hill5/24/2013This bill PASSED the Senate
29 voted YES 4 voted NO 6 voted present/not voting
select this voteAssembly Committee on Business, Professions and Consumer ProtectionDo pass and be re-referred to the Committee on Health.6/25/2013This motion PASSED the Assembly Committee on Business, Professions and Consumer Protection
12 voted YES 0 voted NO 1 voted present/not voting
select this voteAssembly Committee on HealthDo pass as amended and be re-referred to the Committee on Appropriations.7/02/2013This motion PASSED the Assembly Committee on Health
14 voted YES 2 voted NO 3 voted present/not voting
select this voteAssembly Committee on AppropriationsDo pass.8/21/2013This motion PASSED the Assembly Committee on Appropriations
15 voted YES 0 voted NO 2 voted present/not voting
select this voteAssemblySB 598 Hill Senate Third Reading By PAN8/26/2013This bill PASSED the Assembly
60 voted YES 4 voted NO 14 voted present/not voting
currently selectedSenateUnfinished Business SB598 Hill Concurrence9/04/2013This bill PASSED the Senate
30 voted YES 2 voted NO 7 voted present/not voting
ActionDateDescription
Introduced2/22/2013
2/22/2013Introduced. To Com. on RLS. for assignment. To print.
2/23/2013From printer. May be acted upon on or after March 25.
2/25/2013Read first time.
3/11/2013Referred to Coms. on B., P. & E.D. and HEALTH.
3/21/2013Set for hearing April 8.
select this voteVote4/08/2013Do pass as amended, and re-refer to the Committee on Health.
4/15/2013From committee: Do pass as amended and re-refer to Com. on HEALTH. (Ayes 10. Noes 0. Page 464.) (April 8).
4/16/2013Read second time and amended. Re-referred to Com. on HEALTH.
4/23/2013Set for hearing May 1.
select this voteVote5/01/2013Do pass, but re-refer to the Committee on Appropriations.
5/02/2013From committee: Do pass and re-refer to Com. on APPR. (Ayes 6. Noes 1.) (May 1). Re-referred to Com. on APPR.
5/03/2013Set for hearing May 13.
5/07/2013Hearing postponed by committee.
5/10/2013Set for hearing May 20.
5/20/2013From committee: Be placed on second reading file pursuant to Senate Rule 28.8.
5/21/2013Read second time. Ordered to third reading.
5/24/2013Read third time. Passed. (Ayes 29. Noes 4.) Ordered to the Assembly.
5/24/2013In Assembly. Read first time. Held at Desk.
select this voteSenate Vote on Passage5/24/2013Senate 3rd Reading SB598 Hill
6/17/2013Referred to Coms. on B.,P. & C.P. and HEALTH.
6/20/2013From committee with author's amendments. Read second time and amended. Re-referred to Com. on B.,P. & C.P.
6/25/2013From committee: Do pass and re-refer to Com. on HEALTH. (Ayes 12. Noes 0.) (June 25). Re-referred to Com. on HEALTH.
select this voteVote6/25/2013Do pass and be re-referred to the Committee on Health.
select this voteVote7/02/2013Do pass as amended and be re-referred to the Committee on Appropriations.
8/05/2013From committee: Do pass as amended and re-refer to Com. on APPR. (Ayes 14. Noes 2.) (July 2).
8/06/2013Read second time and amended. Re-referred to Com. on APPR.
8/14/2013Hearing postponed by committee.
8/21/2013From committee: Do pass. (Ayes 15. Noes 0.) (August 21).
select this voteVote8/21/2013Do pass.
8/22/2013Read second time. Ordered to third reading.
8/26/2013Read third time. Passed. Ordered to the Senate.
8/26/2013In Senate. Concurrence in Assembly amendments pending.
select this voteAssembly Vote on Passage8/26/2013SB 598 Hill Senate Third Reading By PAN
9/04/2013Assembly amendments concurred in. (Ayes 30. Noes 2.) Ordered to engrossing and enrolling.
currently selectedSenate Vote on Passage9/04/2013Unfinished Business SB598 Hill Concurrence
9/23/2013Enrolled and presented to the Governor at 2 p.m.
Vetoed10/12/2013Vetoed by the Governor.
10/12/2013In Senate. Consideration of Governor's veto pending.
2/27/2014Consideration of Governor's veto stricken from file.

Total contributions given to Senators from interest groups that…

57 Organizations Supported and 21 Opposed; See Which Ones

Organizations that took a position on
An Act to Add Section 4073.5 to the Business and Professions Code, Relating to Pharmacy.: Unfinished Business SB598 Hill Concurrence

57 organizations supported this bill

AbbVie
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Actavis
(2013, August 28). Senate Floor Analysis. Retrieved December 10, 2013, from Leginfo: Bill Analysis.
AIDS Institute
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
AIM Melanoma
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Alliance for Patient Access
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Alliance for Safe Biologic Medicines
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Alliance of Specialty Medicine
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
American Academy of Facial Plastic and Reconstructive Surgery
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
American Association of Neurological Surgeons
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
American Association of People with Disabilities
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
American Autoimmune Related Diseases Association
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
American Council on Science and Health
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
American Gastroenterological Association
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
American Society for Mohs Surgery
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
American Society of Cataract and Refractive Surgery
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
American Society of Echocardiography
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
American Society of Plastic Surgeons
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
American Urological Association
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Amgen
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Association of Black Cardiologists
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Association of Clinical Research Organizations
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Association of Gastrointestinal Motility Disorders
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
BayBio
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Biocom
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Biotechnology Industry Organization
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Blue Ribbon Advocacy Alliance
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
California Healthcare Institute
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
California Medical Association
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
California Prostate Cancer Coalition Advocates
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
California State Association of Electrical Workers
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
coalition of state rheumatology organizations
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Colon Cancer Alliance
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Colorectal Cancer Coalition
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Congress of Neurological Surgeons
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
CONNECT
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Genentech
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
global healthy living foundation
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
HealthHIV
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Interamerican College of Physicians and Surgeons
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
International Cancer Advocacy Network
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
International Myeloma Foundation
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
International Union of Operating Engineers
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Jenny’s Quest-Cure for Pediatric Brain Stem Cancer
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Kidney Cancer Association
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
MANA
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
MedImmune
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Merck
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
National Kidney Foundation
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
National Physicians Biologics Working Group
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
North American Spine Society
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
RetireSafe
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Society for Cardiovascular Angiography and Interventions
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Society for Excellence in Eyecare
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
State Building and Construction Trades Council of California
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
TechNet
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
UCB, Inc.
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Western States Council of Sheet Metal Workers
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.

21 organizations opposed this bill

Anthem
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Boehringer Ingelheim
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
California Association of Health Plans
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
California Conference Board of the Amalgamated Transit Union
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
California Conference of Machinists and Aerospace Workers
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
California Retailers Association
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
California Teamsters Public Affairs Council
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
CVS Caremark
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Engineers and Scientists of California
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Express Scripts
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
IFPTE Local 21
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
International Longshore and Warehouse Union
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Kaiser Permanente
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Mylan
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
National Association of Chain Drug Stores
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Novartis Corporation
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Teva Pharmaceuticals
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
UFCW Western States Council
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
UNITE HERE
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Utility Workers Union of America Local 132
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.
Walgreens
(2013, May 22). Senate Floor Analysis. Retrieved August 26, 2013, from Leginfo: Bill Analysis.

Need proof?

View citations of support and opposition

Includes reported contributions to campaigns of Senators in office on day of vote, from interest groups invested in the vote according to MapLight, January 1, 2009 – December 31, 2012.
Contributions data source: FollowTheMoney.org

Contributions by Legislator

Namesort iconPartyDistrict$ From Interest Groups
That Supported
$ From Interest Groups
That Opposed
Vote
Joel AndersonRCA-36$61,600$44,500
Jim BeallDCA-15$48,400$63,275
Tom BerryhillRCA-14$17,000$27,700
Marty BlockDCA-39$44,950$69,200
Ron CalderonDCA-30$28,900$19,100
Anthony CannellaRCA-12$20,350$33,200
Ellen CorbettDCA-10$28,250$13,100
Lou CorreaDCA-34$58,185$32,450
Mark DeSaulnierDCA-7$80,800$49,450
Bill EmmersonRCA-23$38,644$39,650
Noreen EvansDCA-2$42,500$13,500
Jean FullerRCA-18$33,550$31,175
Ted GainesRCA-1$28,350$94,000
Cathleen GalgianiDCA-5$50,399$87,546
Loni HancockDCA-9$46,500$33,950
Ed HernandezDCA-24$162,848$146,050
Jerry HillDCA-13$112,650$88,531
Ben HuesoDCA-40$52,272$29,800
Bob HuffRCA-29$44,890$64,600
Hannah-Beth JacksonDCA-19$35,011$16,000
Steve KnightRCA-21$16,050$14,650
Ricardo LaraDCA-33$103,900$72,150
Mark LenoDCA-11$37,000$27,850
Ted LieuDCA-28$138,090$78,796
Carol LiuDCA-25$13,600$12,300
Bill MonningDCA-17$98,095$122,503
Jim NielsenRCA-4$27,000$31,600
Alex PadillaDCA-20$70,400$32,500
Fran PavleyDCA-27$23,300$41,998
Richard D. RothDCA-31$7,800$12,350
Darrell SteinbergDCA-6$89,637$48,500
Norma TorresDCA-32$47,728$41,426
Andy VidakRCA-16$0$0
Mimi WaltersRCA-37$53,906$66,950
Lois WolkDCA-3$41,616$23,800
Rod WrightDCA-35$64,174$50,500
Mark WylandRCA-38$47,700$19,250
Leland YeeDCA-8$40,150$19,800
Kevin de LeonDCA-22$121,000$89,116

Add Data Filters:

Legislator Filters
Legislator Filters
NamePartyDistrict$ From Interest Groups
That Supported
$ From Interest Groups
That Opposed
Vote
Joel AndersonRCA-36$61,600$44,500
Jim BeallDCA-15$48,400$63,275
Tom BerryhillRCA-14$17,000$27,700
Marty BlockDCA-39$44,950$69,200
Ron CalderonDCA-30$28,900$19,100
Anthony CannellaRCA-12$20,350$33,200
Ellen CorbettDCA-10$28,250$13,100
Lou CorreaDCA-34$58,185$32,450
Mark DeSaulnierDCA-7$80,800$49,450
Bill EmmersonRCA-23$38,644$39,650
Noreen EvansDCA-2$42,500$13,500
Jean FullerRCA-18$33,550$31,175
Ted GainesRCA-1$28,350$94,000
Cathleen GalgianiDCA-5$50,399$87,546
Loni HancockDCA-9$46,500$33,950
Ed HernandezDCA-24$162,848$146,050
Jerry HillDCA-13$112,650$88,531
Ben HuesoDCA-40$52,272$29,800
Bob HuffRCA-29$44,890$64,600
Hannah-Beth JacksonDCA-19$35,011$16,000
Steve KnightRCA-21$16,050$14,650
Ricardo LaraDCA-33$103,900$72,150
Mark LenoDCA-11$37,000$27,850
Ted LieuDCA-28$138,090$78,796
Carol LiuDCA-25$13,600$12,300
Bill MonningDCA-17$98,095$122,503
Jim NielsenRCA-4$27,000$31,600
Alex PadillaDCA-20$70,400$32,500
Fran PavleyDCA-27$23,300$41,998
Richard D. RothDCA-31$7,800$12,350
Darrell SteinbergDCA-6$89,637$48,500
Norma TorresDCA-32$47,728$41,426
Andy VidakRCA-16$0$0
Mimi WaltersRCA-37$53,906$66,950
Lois WolkDCA-3$41,616$23,800
Rod WrightDCA-35$64,174$50,500
Mark WylandRCA-38$47,700$19,250
Leland YeeDCA-8$40,150$19,800
Kevin de LeonDCA-22$121,000$89,116

Interest Groups that supported this bill

$ Donated
Construction unions$2,597,081
Pharmaceutical manufacturing$828,462
Electrical workers/IBEW$616,225
Physicians$439,548
Optometrists & ophthalmologists$314,574
Other physician specialists$291,140
Biotech products & research$160,700
Health & welfare policy$68,491
Computer manufacture & services$48,900
Credit reporting services & collection agencies$44,000
Manufacturing$40,008
Medical laboratories$32,852
Republican-based groups (but not official party committees) and generic conservative ones$20,756
Human rights$0
Health, education & human resources$0

Interest Groups that opposed this bill

$ Donated
Construction unions$2,597,081
Pharmaceutical manufacturing$828,462
Accident & health insurance$681,242
HMOs$251,778
Drug stores$231,304
Teamsters unions$163,047
Labor unions$156,350
Health care services$147,156
Transportation unions$82,100
Merchant marine & longshoremen unions$63,850
Retail trade$25,989
General commercial unions$0
Food service & related unions$0
Energy-related unions (non-mining)$0
Loading…
Date Range of Contributions
Enter a custom date range